SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDE.L Regulatory News (IDE)

  • There is currently no data for IDE

Loan Note Issue

10 Jan 2019 07:00

RNS Number : 6842M
IDE Group Holdings PLC
10 January 2019
 

IDE Group Holdings Plc

("IDE", the "Group" or the "Company")

 

£10 million Loan Note Issue

 

 

IDE, the mid-market network, cloud and IT Managed Services provider, announces that it proposes to raise £10 million by way of an issue of secured loan notes ("LNs") in two tranches. Under the first tranche, £5.3 million of LNs (the "First Tranche LNs") have been subscribed for by two existing shareholders of the Company, MXC Guernsey Limited ("MXC"), a wholly owned subsidiary of MXC Capital Limited, and Blake Holdings Limited ("Blake"), a company controlled by Richard Griffiths (the "Initial Subscribers"). The second tranche of £4.7 million (the "Second Tranche LNs") will be made available to all other shareholders by way of an open offer (the "Open Offer"). The proceeds of the issue of the First and Second Tranche LNs will be used to repay IDE's £8.25 million debt facilities with National Westminster Bank plc ("Natwest") consisting of a revolving credit facility ("RCF") of £4.75 million and an overdraft of £3.5 million (together, the "Facilities") and to provide additional working capital for the Company.

 

Background to and Reasons for the LN Issue

 

On 15 October 2018 the Company announced the completion of its strategic and operational review and the sale of 365 ITMS Limited, one of the Group's subsidiaries. It also announced that the restructuring of the businesses that remained within the Group, being IDE Group Manage Limited and IDE Group Connect Limited, was ongoing.

 

To that end, a total of £7.2 million of annualised staff cost reductions have been implemented, along with other operational cost savings including, inter alia, a reduction in software licencing costs and property costs. The Company has also reached a settlement in relation to an outsourced service contract which will result in a saving of c.£3 million over the next three years. The Directors believe that following these cost savings, the Group now has a proportionate cost base.

 

The Directors are also pleased to announce that in addition to this progress having been made in relation to the Group's cost base, several of the Group's material customers have renewed their contracts with IDE, some on a multi-year basis; these contracts have a total contract value of c.£3.6 million. The Directors believe that this is testament to the level of service IDE provides.

 

Throughout the difficulties that faced IDE during 2018, the Group's bankers, Natwest, remained supportive of the Company. The proceeds of the 365 Sale were used to reduce IDE's level of debt, however, the Group's remaining RCF of £4.75 million is fully drawn and it has c.£1 million headroom on its £3.5 million overdraft facility. Natwest has informed the Company that it would like full repayment of the Facilities and the Directors believe that the LN Issue will enable IDE to repay the Facilities, provide additional working capital and deliver longer-term funding for the Group, thereby affording security for all the Group's stakeholders.

 

Terms of the LNs

 

The LNs have a term of six years (the "Term") and an annual coupon of 12%, which is rolled up, compounded annually and payable at the end of the Term. The LNs carry an arrangement fee of 2.5 per cent., payable at the end of Term, and an exit fee of 2.5 per cent., also payable at the end of the Term. The LNs are secured on the Company's assets, though the First Tranche LNs are subordinated to the Facilities with Natwest until such Facilities have been fully repaid. Thereafter, the LNs will have first charge over the Company's assets. The LNs can be redeemed at any time at the Company's option, however, should the Company opt to redeem the LNs prior to the end of the Term, all interest due until the end of the Term will become payable, together with the arrangement and exit fees, upon such early redemption.

 

The Open Offer

 

In order to allow all shareholders of the Company to participate on the same terms as the Initial Subscribers, under the terms of the Open Offer, qualifying shareholders will be invited to subscribe for the Second Tranche LNs, pro rata (over all the LNs) to their existing shareholdings on the basis of 1 £1 LN for every 40 existing ordinary shares held as at the record date, being 5.00 p.m. on or around 9 January 2018, at a price of £1 per LN, payable in full on application and free of all expenses.

 

The First Tranche LNs represent the pro-rata entitlement of the Initial Subscribers of the total £10 million of loan notes to be issued, being £4.3 million for MXC and £1 million for Blake. Therefore, MXC and Blake are not entitled to participate in the Open Offer. However, the Company and MXC have entered into an underwriting agreement whereby to the extent that other shareholders do not subscribe for all the Second Tranche LNs, MXC will forthwith subscribe for any balance of such Second Tranche LNs not so subscribed for (the "Underwriting Agreement"). Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel"), a 9.1 per cent. shareholder of the Company, has undertaken to fully subscribe for its entitlement to the Second Tranche LNs, being £0.9 million.

 

A further announcement in respect of the Open Offer and details of how to subscribe for the Second Tranche LN's will be made in due course. It is expected that the Open Offer will complete in February.

 

The MXC Underwriting Agreement and Guarantee

 

The Company and MXC have entered into the Underwriting Agreement under which IDE will pay MXC a fee equal to 5 per cent. of the value of the Second Tranche LNs subscribed for by it and a fee equal to 2.5 per cent. of those Second Tranche LNs subscribed for by other shareholders.

 

MXC has also given a guarantee in favour of Natwest (the "Guarantee") whereby MXC has agreed to guarantee IDE's RCF with Natwest and under which it has, inter alia, undertaken with Natwest that if IDE does not pay any amount due under the RCF it shall upon demand pay that amount as if it were the principal debtor. MXC is not receiving a fee for providing the Guarantee.

 

As MXC is a substantial shareholder of the Company, it is deemed to be a related party pursuant to the AIM Rules for Companies (the "AIM Rules"). The entry into the Underwriting Agreement is therefore a related party transaction for the purposes of Rule 13 of the AIM Rules. Ian Smith, Executive Director, is not independent for the purposes of the related party transaction given that he is a substantial shareholder and CEO of MXC. The other directors of IDE, Andy Parker and Max Royde, are both deemed independent for these purposes and consider, having consulted with the Company's nominated adviser, finnCap, that the terms of the related party transaction are fair and reasonable insofar as the shareholders of the Company are concerned.

 

Andy Parker, Executive Chairman of IDE, commented:

 

"I am pleased to be able to announce that we have secured new debt funding for IDE and that we are able to offer all shareholders the opportunity to participate in such funding. The Loan Notes provide long term funding for the Group, providing a secure financial platform on which we can build. Significant work has been put into right-sizing the business and I am pleased with the progress we have made. We start the new financial year with a cost base proportionate to our level of contracted revenue."

 

Market Abuse Regulation (MAR) Disclosure

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

IDE Group Holdings Plc

Andy Parker, Executive Chairman

 

 

Tel: +44 (0)344 874 1000

finnCap Limited

Nominated Adviser and Broker

Corporate finance: Jonny Franklin-Adams/ Scott Mathieson/ Hannah Boros

ECM: Tim Redfern/ Richard Chambers

 

Tel: +44 (0)20 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODSSMEFUFUSEEF
Date   Source Headline
20th Apr 20217:00 amRNSDirectorate Change
15th Feb 20217:00 amRNSResignation of Director
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 202111:06 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
28th Jan 202111:05 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
4th Jan 20217:00 amRNSContract Win
24th Dec 202011:06 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
24th Dec 20209:05 amRNSSecond Price Monitoring Extn
24th Dec 20209:00 amRNSPrice Monitoring Extension
4th Dec 20202:06 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
3rd Dec 20204:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:01 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:00 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
20th Nov 20202:06 pmRNSSecond Price Monitoring Extn
20th Nov 20202:01 pmRNSPrice Monitoring Extension
16th Nov 202010:11 amRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSHalf-year Report
4th Sep 202011:24 amRNSResult of AGM
10th Aug 202012:05 pmRNSNotice of Annual General Meeting
14th Jul 20207:00 amRNSFinal Results
30th Jun 20207:00 amRNSDelay of Full Year Results and Trading Update
5th Jun 202012:17 pmRNSChange of Directorate Position
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
24th Feb 20202:16 pmRNSHolding(s) in Company
20th Feb 20203:24 pmRNSDirector/PDMR Shareholding
15th Jan 20202:32 pmRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSIssue of Loan Notes and Contract Wins
13th Nov 20199:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.